J0791
HCPCSInj crizanlizumab-tmca 5mg
Official HCPCS Level II long descriptor
Injection, crizanlizumab-tmca, 5 mg
HCPCS Level II code J0791 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj crizanlizumab-tmca 5mg
Added to HCPCS: 2020-07-01
Nearby codes in J0
- J0745Inj codeine phosphate /30 mg
- J0750Hiv prep, ftc/tdf 200/300mg
- J0751Hiv prep, ftc/taf 200/25mg
- J0752Hiv prep, oral lenacapavir
- J0759Inj, clevidipine, 1 mg
- J0770Colistimethate sodium inj
- J0775Collagenase, clost hist inj
- J0780Prochlorperazine injection
- J0799Hiv prep, fda approved, noc
- J0801Inj. acthar gel to 40 units
- J0802Inj. (ani), up to 40 units
- J0834Inj., cosyntropin, 0.25 mg
- J0840Crotalidae poly immune fab
- J0841Inj crotalidae im f(ab')2 eq
- J0850Cytomegalovirus imm iv /vial
- J0870Injection, imetelstat, 1 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.